Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Astbury

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Annals of the Rheumatic Diseases|August 1, 1990
Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel diseaseC Astbury, A J Taggart, L Juby, et al.
British Journal of Rheumatology|December 1, 1990
Methylsulphasalazine in rheumatoid arthritisC Astbury, J Hill, J R Lowe, et al.
SSM - Population Health|June 11, 2021
An exploration of how meal preparation activities relate to self-rated time pressure, stress, and health in Canada: A time use approachMichael J Widener, Linda Ren, Chloe C Astbury, et al.
Public Health|August 19, 2022
Making integration foundational in population health intervention research: why we need 'Work Package Zero'M Alvarado, T L Penney, C C Astbury, et al.
British Journal of Rheumatology|June 1, 1993
Optimizing the assessment of disease activity during treatment with anti-rheumatoid drugsC Astbury, R Platt, J S Dixon, et al.
British Journal of Rheumatology|February 1, 1987
Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritisA J Taggart, J Hill, C Astbury, et al.
Genes, Chromosomes & Cancer|April 25, 2001
Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell-mediated restoration of chromosome 19C Astbury, C K Jackson-Cook, S H Culp, et al.
The Journal of Rheumatology|June 1, 1994
Phenotype/genotype relationships for the cytochrome P450 enzyme CYP2D6 in rheumatoid arthritis: influence of drug therapy and disease activityC Beyeler, A K Daly, M Armstrong, et al.
Drugs|January 1, 1986
5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?A J Taggart, V C Neumann, J Hill, et al.
The Journal of Rheumatology|April 1, 1986
A study to determine the active moiety of sulphasalazine in rheumatoid arthritisV C Neumann, A J Taggart, P Le Gallez, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|August 1, 1990
Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel diseaseC Astbury, A J Taggart, L Juby, et al.
British Journal of Rheumatology|December 1, 1990
Methylsulphasalazine in rheumatoid arthritisC Astbury, J Hill, J R Lowe, et al.
SSM - Population Health|June 11, 2021
An exploration of how meal preparation activities relate to self-rated time pressure, stress, and health in Canada: A time use approachMichael J Widener, Linda Ren, Chloe C Astbury, et al.
Public Health|August 19, 2022
Making integration foundational in population health intervention research: why we need 'Work Package Zero'M Alvarado, T L Penney, C C Astbury, et al.
British Journal of Rheumatology|June 1, 1993
Optimizing the assessment of disease activity during treatment with anti-rheumatoid drugsC Astbury, R Platt, J S Dixon, et al.
British Journal of Rheumatology|February 1, 1987
Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritisA J Taggart, J Hill, C Astbury, et al.
Genes, Chromosomes & Cancer|April 25, 2001
Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell-mediated restoration of chromosome 19C Astbury, C K Jackson-Cook, S H Culp, et al.
The Journal of Rheumatology|June 1, 1994
Phenotype/genotype relationships for the cytochrome P450 enzyme CYP2D6 in rheumatoid arthritis: influence of drug therapy and disease activityC Beyeler, A K Daly, M Armstrong, et al.
Drugs|January 1, 1986
5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?A J Taggart, V C Neumann, J Hill, et al.
The Journal of Rheumatology|April 1, 1986
A study to determine the active moiety of sulphasalazine in rheumatoid arthritisV C Neumann, A J Taggart, P Le Gallez, et al.
Pageof 5